Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission.
作者信息
Fouda Genevieve G, Cunningham Coleen K, Permar Sallie R
机构信息
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina2Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina.
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
出版信息
JAMA. 2015 Apr 21;313(15):1513-4. doi: 10.1001/jama.2015.1382.
Abstract
摘要
相似文献
1
Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission.婴儿HIV-1疫苗：减少母婴传播的补充策略
JAMA. 2015 Apr 21;313(15):1513-4. doi: 10.1001/jama.2015.1382.
2
Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.预防HIV-1母婴传播的免疫预防措施。
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):169-77. doi: 10.1097/00126334-200402010-00012.
3
Breast milk transmission of HIV-1. Laboratory and clinical studies.人类免疫缺陷病毒1型的母乳传播。实验室及临床研究。
Ann N Y Acad Sci. 2000 Nov;918:122-7. doi: 10.1111/j.1749-6632.2000.tb05480.x.
4
The prevention of maternal-fetal HIV-1 infection through passive antibody products (HIVIG) and active immunization (AIDS vaccines).通过被动抗体产品（HIV免疫球蛋白）和主动免疫（艾滋病疫苗）预防母婴HIV-1感染。
Pediatr AIDS HIV Infect. 1995 Oct;6(5):300-2.
5
Efforts to prevent mother-to-child transmission of human immunodeficiency virus type 1 through human milk: past, present, and future.通过母乳预防母婴传播1型人类免疫缺陷病毒的努力：过去、现在和未来。
Adv Exp Med Biol. 2004;554:475-80. doi: 10.1007/978-1-4757-4242-8_68.
6
Human immunodeficiency virus in breast milk.母乳中的人类免疫缺陷病毒。
Med Hypotheses. 1998 Jul;51(1):75-7. doi: 10.1016/s0306-9877(98)90259-6.
7
Antiretroviral Prophylaxis to Reduce Breast Milk Transmission of HIV Type 1: New Data but Still Questions.抗逆转录病毒预防措施以减少1型艾滋病毒的母乳传播：新数据但仍有问题。
J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):237-40. doi: 10.1097/QAI.0b013e31817dc89e.
8
Transmission of HIV-1 in the breast-feeding process.HIV-1在母乳喂养过程中的传播。
J Am Diet Assoc. 1996 Mar;96(3):267-74; quiz 275-6. doi: 10.1016/S0002-8223(96)00079-X.
9
Vaccines for control of AIDS--an update.
Indian J Pediatr. 1994 Sep-Oct;61(5):535-43. doi: 10.1007/BF02751714.
10
Preventive strategies for pediatric AIDS.
Indian J Pediatr. 1994 Sep-Oct;61(5):491-6. doi: 10.1007/BF02751709.
引用本文的文献
1
Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets.儿童和成人在95-95-95目标达成方面存在相当大的差异，这可能会延迟既定目标的实现。
Front Public Health. 2025 Apr 29;13:1565242. doi: 10.3389/fpubh.2025.1565242. eCollection 2025.
2
Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model.评估 repRNA 疫苗在怀孕兔模型中诱导和宫内转移母源抗体的效果。
Mol Ther. 2023 Apr 5;31(4):1046-1058. doi: 10.1016/j.ymthe.2023.02.022. Epub 2023 Mar 24.
3
Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.围产期传播的婴儿传播/创始 HIV-1 病毒对配对的母体血浆具有中和抗性。
PLoS Pathog. 2018 Apr 19;14(4):e1006944. doi: 10.1371/journal.ppat.1006944. eCollection 2018 Apr.
4
Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1-Exposed Ugandan Infants.在乌干达感染HIV-1的婴儿纯母乳喂养和非纯母乳喂养期间，对HIV-1具有表型易感性的CD4+ T淋巴细胞的个体发生。
J Infect Dis. 2017 Feb 1;215(3):368-377. doi: 10.1093/infdis/jiw553.
本文引用的文献
1
PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.PedVacc 002：一项针对内罗毕地区人类免疫缺陷病毒1型阳性母亲所生婴儿接种MVA.HIVA疫苗的I/II期随机临床试验。
Vaccine. 2014 Oct 7;32(44):5801-8. doi: 10.1016/j.vaccine.2014.08.034. Epub 2014 Aug 27.
2
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.婴儿HIV-1型gp120疫苗接种引发强烈且持久的抗V1V2免疫球蛋白G反应，仅引发罕见的包膜特异性免疫球蛋白A反应。
J Infect Dis. 2015 Feb 15;211(4):508-17. doi: 10.1093/infdis/jiu444. Epub 2014 Aug 27.
3
Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.在乌干达，使用 ALVAC-HIV vCP1521 疫苗对 HIV 暴露婴儿的可行性和安全性：非洲首例婴儿 HIV 疫苗试验的结果。
J Acquir Immune Defic Syndr. 2013 May 1;63(1):1-8. doi: 10.1097/QAI.0b013e31827f1c2d.
4
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.HIV-1 疫苗功效试验的免疫相关性分析。
N Engl J Med. 2012 Apr 5;366(14):1275-86. doi: 10.1056/NEJMoa1113425.
5
The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.母亲在妊娠晚期和哺乳期 HIV 血清转化对母婴 HIV 传播的影响。
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):417-25. doi: 10.1097/QAI.0b013e3182432f27.
6
What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs.实现艾滋病母婴传播的虚拟消除需要什么？对当前进展和未来需求的评估。
Sex Transm Infect. 2010 Dec;86 Suppl 2(Suppl_2):ii48-55. doi: 10.1136/sti.2010.045989.
7
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.南非约翰内斯堡高效抗逆转录病毒治疗持续时间和方案对母婴传播艾滋病毒风险的影响。
J Acquir Immune Defic Syndr. 2010 May 1;54(1):35-41. doi: 10.1097/QAI.0b013e3181cf9979.
8
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
9
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.HIV-1疫苗在感染HIV-1的母亲的新生儿中诱导的免疫反应。
AIDS. 2006 Jul 13;20(11):1481-9. doi: 10.1097/01.aids.0000237363.33994.45.
10
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
Clin Infect Dis. 2001 Mar 1;32(5):801-7. doi: 10.1086/319215. Epub 2001 Feb 28.
Zotero 插件